The N-terminal domain of thrombospondin-1: A key for the dual effect of TSP-1 in angiogenesis and cancer progression?

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 133-136

  Morandi, Verônica ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiogenesis; Heparin binding domain; Syndecan 4; Thrombospondin 1

Indexed keywords

HEPARIN BINDING PROTEIN; SYNDECAN 4; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; HUMAN; LIVER CELL CARCINOMA; PROTEIN ANALYSIS; ANIMAL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; THROMBOSPONDIN 1;

EID: 63649153116     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.11     Document Type: Article

References (35)

1. Calzada, M.J. and Roberts, D.D. (2005) Novel integrin antagonists derived from thrombospondins. Curr. Pharm. Des. 11, 849-866.
2. Baezinger, N.L., Brodie, G.N., and Majerus, P.W. (1971) A thrombin-sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. U. S. A. 68, 240-243.
3. Kazerounian, S., Yee, K.O., and Lawler, J. (2008) Thrombospondin in cancer. Cell. Mol. Life Sci. 75, 700-712.
4. Good, D.J., Polverini, P.J., Rastinejad, F., Le Beau, M.M., Lemons, R.S., Frazier, W.A., Bouck, N.P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U. S. A. 87, 6624-6628. (Pubitemid 20351533)
5. Tolsma, S.S., Volpert, O.V., Good, D.J., Frazier, W.A., Polverini, P.J., and Bouck, N. (1993) Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity. J. Cell Biol. 122, 497-511. (Pubitemid 23210475)
6. Guo, N., Krutsch, H.C., Inman, J.K., and Roberts, D.D. (1997) Thrombospondin-1 and type I repeat peptides of thrombospondin-1 specifically induce apoptosis of endothelial cells. Cancer Res. 57, 1735-1742. (Pubitemid 27199668)
7. Jiménez, B., Volpert, O., Crawford, E., Febbraio, M., Silverstein, R., and Bouck, N. (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6, 41-48. (Pubitemid 30048524)
8. Ren, B., Yee, K.O., Lawler, J., and Khosravi-Far, R. (2006) Regulation of tumor angiogenesis by thrombospondin-1. Biochem. Biophys. Acta 1765, 178-188.
9. Murphy-Ullrich, J.E. and Poczatek, M. (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11, 59-69.
10. Tuszynski, G.P., Gasic, T.B., Rothman, V.L., Nudsen, K.A., and Gasic, G.J. (1987) Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res. 47, 4130-4133. (Pubitemid 17108482)
11. Taraboletti, G., Roberts, D.D., and Liotta, L.A. (1987) Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J. Biol. Chem. 105, 2409-2415. (Pubitemid 18019089)
12. Wang, T.N., Qian, X., Granick, M.S., Solomon, M.P., Rothman, V.L., Berger, D.H., and Tuszynski, G.P. (1996) Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J. Surg. Res. 63, 39-43. (Pubitemid 26197174)
13. Brown, L.F., Guidi, A.J., Schnitt, S.J., Van de Water, L., Iruela-Arispe, M.L., Yeo, T.K., Tognazzi, K., and Dvorak, H.F. (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5, 1041-1056. (Pubitemid 29233218)
14. Bertin, N., Clezardin, P., Kubiak, R. and Frappart, L. (1997) Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res. 57, 396-399. (Pubitemid 27081653)
15. Byrne, G.J., Hayden, K.E., McDowell, G., Lang, H., Kirwan, C.C., Tetlow, L., Kumar, S., and Bundred, N.J. (2007) Angiogenic characteristics of circulating and tumoral thrombospondin-1 in breast cancer. Int. J. Oncol. 31, 1127-1132.
16. Incardona, F., Lewalle, J.M., Morandi, V., Lambert, S., Legrand, Y., Foidart, J.M., and Legrand, C. (1995) Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res. 55, 166-173.
17. Poon, R.T., Chung, K.K., Cheung, S.T., Lau, C.P., Tong, S.W., Leung, K.L., Yu, W.C., Tuszynski, G., and Fan, S.T. (2004) Clinical significance of thrombospondin expression in hepatocellular carcinoma. Clin. Cancer Res. 10, 4150-4157. (Pubitemid 38812495)
18. Maeda, K., Nishiguchi, Y., Yashiro, M., Yamada, S., Onoda, N., Sawada, T., Kang, S.M., and Hirakawa, K. (2000) Expression of vascular endothelial factor and thrombospondin-1 in colorectal carcinoma. Int. J. Mol. Med. 5, 373-378.
19. Maeda, K., Nishiguchi, Y., Kang, S.M., Yashiro, M., Onoda, N., Sawada, T., Ishikawa, T., and Hirakawa, K. (2001) Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol. Rep. 8, 763-766. (Pubitemid 33758118)
20. Sutton, C.D., O'Byrne, K., Goddard, J.C., Marshall, L., Jones, L., Garcea, G., Dennison, A.R., Poston, G., Lloyd, D.M., and Berry, D.P. (2005) Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis. Clin. Cancer Res. 11, 6567-6573. (Pubitemid 41338996)
21. Elzie, C.A. and Murphy-Ullrich, J.E. (2004) The N-terminus of thrombospondin: the domain stands apart. Int. J. Biochem. Cell Biol. 36, 1090-1101.
22. Chandrasekaran, L., Chao-Zhen, H., Al-Barazi, H., Krutzsch, H.C., Iruela-Arispe, M.L., and Roberts, D.D. (2000) Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol. Biol. Cell 11, 2885-2890. (Pubitemid 32107072)
23. Taraboletti, G., Morbidelli, L., Donnini, S. Parenti, A., Granger, H., Giavazzi, R., and Ziche, M. (2000) The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. FASEB J. 14, 1674-1676. (Pubitemid 30688615)
24. Ferrari-do-Outeiro-Bernstein, M.A., Nunes, S.S., Andrade, A.C.M., Alves, T.R., Legrand, C., and Morandi, V. (2002) A recombinant NH2-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Matrix Biol. 21, 311-324. (Pubitemid 34786469)
25. Nunes, S.S., Ferrari do Outeiro-Bernstein, M., Juliano, L., Nader, H.B., Woods, A., Legrand, C., and Morandi, V. (2008) Syndecan-4 contributes to endothelial tubulogenesis and survival through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1. J. Cell. Physiol. 214, 828-837.
26. Murphy-Ullrich, J.E., Gurusiddappa, S., Frazier, W.A., and Höök, M. (1993) Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J. Biol. Chem. 268, 26784-26789. (Pubitemid 23361768)
27. Woods, A., McCarthy, J.B., Furcht, L.T., and Couchman, J.R. (1993) A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell 4, 605-613. (Pubitemid 23183608)
28. Pallero, M.A., Elzie, C.A., Chen, J., Mosher, D.F., and Murphy-Ullrich, J.E. (2008) Thrombospondin-1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J. 22, 1-12.
29. 2-terminal heparin-binding fragment of human endothelial thrombospondin. FEBS Lett. 346, 156-160.
30. Bonnefoy, A. and Legrand, C. (2000) Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb. Res. 98, 323-332. (Pubitemid 30255936)
31. Lee, N.V., Sato, M., Annis, D.S., Loo, J.A., Wu, L., Mosher, D.F., and Iruela-Arispe, M.L. (2006) ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J. 25, 5270-5283. (Pubitemid 44764137)
32. Filleur, S., Volpert, O.V., Degeorges, A., Voland, C., Reiher, F., Clézardin, P., Bouck, N., and Cabon, F (2001) In vivo mechanisms by which tumors producing thrombospondin-1 bypass its inhibitory effects. Genes Dev. 15, 1373-1382. (Pubitemid 32524644)
33. Fontana, A., Filleur, S., Guglielmi, J., Frappart, L., Bruno-Bossio, G., Boissier, S., Cabon, F., and Clézardin, P (2005) Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int. J. Cancer. 116, 686-691. (Pubitemid 41099699)
34. Zhang, X. and Lawler, J. (2007) Thrombospondin-based antiangiogenic therapy. Microvasc. Res. 74, 90-99.
35. Echtermeyer, F., Streit, M., Wilcox-Aldeman, S., Saoncella, S., Denhez, F., Detmar, M., and Goetinck, P.F. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9-R14. (Pubitemid 32096841)